Patents by Inventor Romain Rouet

Romain Rouet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11332522
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: May 17, 2022
    Assignee: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Patent number: 10851367
    Abstract: The present application provides compounds, compositions, uses thereof for the treatment of diseases, conditions and/or disorders, and uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: December 1, 2020
    Assignees: Pfizer Inc., The Regents of the University of California
    Inventors: Spiros Liras, Vincent Mascitti, Benjamin Aaron Thuma, Jennifer A. Doudna, Romain Rouet
  • Publication number: 20200102376
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: May 9, 2019
    Publication date: April 2, 2020
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20170240619
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: November 7, 2016
    Publication date: August 24, 2017
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20170137801
    Abstract: The present application provides compounds, compositions, uses thereof for the treatment of diseases, conditions and/or disorders, and uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.
    Type: Application
    Filed: November 9, 2016
    Publication date: May 18, 2017
    Inventors: Spiros Liras, Vincent Mascitti, Benjamin Aaron Thuma, Jennifer A. Doudna, Romain Rouet
  • Patent number: 9527908
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: December 27, 2016
    Assignee: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Publication number: 20150307599
    Abstract: The present disclosure provides proteins comprising antibody variable regions that bind specifically to NPY and PYY and uses thereof and methods of treating or preventing cancer or inducing an immune response by inhibiting NPY and PYY.
    Type: Application
    Filed: December 3, 2012
    Publication date: October 29, 2015
    Inventors: Martijn Bijker, Herbert Herzog, Fabienne McKay, Romain Rouet, Peter Schofield, David Zahra, Daniel Christ
  • Publication number: 20140234218
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 15, 2013
    Publication date: August 21, 2014
    Applicant: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet